• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Advances in clinical translation of stem cell-based therapy in neurological diseases.基于干细胞的疗法在神经疾病临床转化方面的进展。
J Cereb Blood Flow Metab. 2025 Apr;45(4):600-616. doi: 10.1177/0271678X251317374. Epub 2025 Jan 30.
2
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.神经障碍的干细胞疗法:当前进展、挑战与未来展望。
Eur J Med Res. 2024 Jul 25;29(1):386. doi: 10.1186/s40001-024-01987-1.
3
Translational insights into stem cell preconditioning: From molecular mechanisms to preclinical applications.转化视角下的干细胞预处理:从分子机制到临床前应用。
Biomed Pharmacother. 2021 Oct;142:112026. doi: 10.1016/j.biopha.2021.112026. Epub 2021 Aug 16.
4
Preclinical assessment of stem cell therapies for neurological diseases.用于神经疾病的干细胞疗法的临床前评估。
ILAR J. 2009;51(1):24-41. doi: 10.1093/ilar.51.1.24.
5
Stem Cell Interventions in Neurology: From Bench to Bedside.神经科学中的干细胞干预:从基础到临床。
J Alzheimers Dis. 2024;101(s1):S395-S416. doi: 10.3233/JAD-230897.
6
Therapeutic potential of human adipose-derived stem cells in neurological disorders.人脂肪来源干细胞在神经疾病中的治疗潜力
J Pharmacol Sci. 2014;126(4):293-301. doi: 10.1254/jphs.14R10CP. Epub 2014 Nov 18.
7
Stem cell-based cell therapy in neurological diseases: a review.基于干细胞的细胞疗法在神经疾病中的应用:综述
J Neurosci Res. 2009 Aug 1;87(10):2183-200. doi: 10.1002/jnr.22054.
8
The potential of stem cell therapies for neurological diseases.干细胞疗法治疗神经疾病的潜力。
Expert Rev Neurother. 2006 Feb;6(2):153-61. doi: 10.1586/14737175.6.2.153.
9
Cell therapies for neurological disease--from bench to clinic to bench.用于神经疾病的细胞疗法——从实验室到临床再回到实验室
Expert Opin Biol Ther. 2005 Mar;5(3):289-91. doi: 10.1517/14712598.5.3.289.
10
Stem cell applications in regenerative medicine for neurological disorders.干细胞在神经退行性疾病再生医学中的应用。
Cell Transplant. 2013;22(4):631-7. doi: 10.3727/096368912X655145. Epub 2012 Oct 31.

引用本文的文献

1
Perspectives in Amyotrophic Lateral Sclerosis: Biomarkers, Omics, and Gene Therapy Informing Disease and Treatment.肌萎缩侧索硬化症的展望:生物标志物、组学及为疾病与治疗提供信息的基因疗法
Int J Mol Sci. 2025 Jun 13;26(12):5671. doi: 10.3390/ijms26125671.
2
Research Progress on the Therapeutic Mechanisms of Stigmasterol for Multiple Diseases.豆甾醇治疗多种疾病的作用机制研究进展
Molecules. 2025 Apr 23;30(9):1874. doi: 10.3390/molecules30091874.

本文引用的文献

1
Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles.细胞外囊泡在脑卒中鼻内递送达干细胞中的作用
Stem Cells Transl Med. 2024 Nov 12;13(11):1043-1052. doi: 10.1093/stcltm/szae072.
2
Mesenchymal stem cells overexpressing XIST induce macrophage M2 polarization and improve neural stem cell homeostatic microenvironment, alleviating spinal cord injury.过表达XIST的间充质干细胞诱导巨噬细胞M2极化并改善神经干细胞稳态微环境,减轻脊髓损伤。
J Tissue Eng. 2024 Jan 10;15:20417314231219280. doi: 10.1177/20417314231219280. eCollection 2024 Jan-Dec.
3
Engineered stem cell-based strategy: A new paradigm of next-generation stem cell product in regenerative medicine.基于工程化干细胞的策略:再生医学中新一代干细胞产品的新模式。
J Control Release. 2024 Jan;365:981-1003. doi: 10.1016/j.jconrel.2023.12.024. Epub 2023 Dec 21.
4
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.用于帕金森病临床试验的人胚胎干细胞衍生多巴胺能祖细胞的临床前和剂量范围评估。
Cell Stem Cell. 2024 Jan 4;31(1):25-38.e8. doi: 10.1016/j.stem.2023.11.009. Epub 2023 Dec 11.
5
Versatile guardians: regenerative regulatory T cells in Parkinson's disease rodent models.多功能守护者:帕金森病啮齿动物模型中的再生调节性T细胞
Signal Transduct Target Ther. 2023 Nov 20;8(1):430. doi: 10.1038/s41392-023-01681-4.
6
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.人胚胎干细胞源性产品治疗帕金森病的临床前质量、安全性和有效性,STEM-PD。
Cell Stem Cell. 2023 Oct 5;30(10):1299-1314.e9. doi: 10.1016/j.stem.2023.08.014.
7
Corrigendum: Potential of cellular therapy for ALS: current strategies and future prospects.勘误:细胞疗法治疗肌萎缩侧索硬化症的潜力:当前策略与未来前景。
Front Cell Dev Biol. 2023 Sep 19;11:1292681. doi: 10.3389/fcell.2023.1292681. eCollection 2023.
8
Cell-therapy for Parkinson's disease: a systematic review and meta-analysis.帕金森病的细胞治疗:系统评价和荟萃分析。
J Transl Med. 2023 Sep 7;21(1):601. doi: 10.1186/s12967-023-04484-x.
9
A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease.采用细胞疗法恢复阿尔茨海默病小鼠模型中小胶质细胞 Trem2 功能。
Cell Stem Cell. 2023 Aug 3;30(8):1043-1053.e6. doi: 10.1016/j.stem.2023.07.006.
10
Co-transplantation of autologous T cells in a cell therapy for Parkinson's disease.自体 T 细胞共移植治疗帕金森病的细胞疗法。
Nature. 2023 Jul;619(7970):606-615. doi: 10.1038/s41586-023-06300-4. Epub 2023 Jul 12.

基于干细胞的疗法在神经疾病临床转化方面的进展。

Advances in clinical translation of stem cell-based therapy in neurological diseases.

作者信息

Wang Yu, Cao Yirong, Xie Wanqing, Guo Yunlu, Cai Jiayi, Huang Tingting, Li Peiying

机构信息

Clinical Research Center, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

J Cereb Blood Flow Metab. 2025 Apr;45(4):600-616. doi: 10.1177/0271678X251317374. Epub 2025 Jan 30.

DOI:10.1177/0271678X251317374
PMID:39883811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11783424/
Abstract

Stem cell-based therapies have raised considerable interest to develop regenerative treatment for neurological disorders with high disability. In this review, we focus on recent preclinical and clinical evidence of stem cell therapy in the treatment of degenerative neurological diseases and discuss different cell types, delivery routes and biodistribution of stem cell therapy. In addition, recent advances of mechanistic insights of stem cell therapy, including functional replacement by exogenous cells, immunomodulation and paracrine effects of stem cell therapies are also demonstrated. Finally, we also highlight the adjunction approaches that has been implemented to augment their reparative function, survival and migration to target specific tissue, including stem cell preconditioning, genetical engineering, co-transplantation and combined therapy.

摘要

基于干细胞的疗法引发了人们极大的兴趣,以开发针对高度致残性神经系统疾病的再生治疗方法。在这篇综述中,我们重点关注干细胞疗法在治疗退行性神经疾病方面的最新临床前和临床证据,并讨论干细胞疗法的不同细胞类型、递送途径和生物分布。此外,还展示了干细胞疗法机制研究的最新进展,包括外源性细胞的功能替代、免疫调节和干细胞疗法的旁分泌作用。最后,我们还强调了为增强其修复功能、存活能力以及向特定靶组织迁移而实施的辅助方法,包括干细胞预处理、基因工程、联合移植和联合治疗。